Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2011-08-30

Clinical Trial Update: Bioavailability Study Comparing 10 mg Amlodipine Besylate Orally Disintegrating Tablets (ODT) And 10 mg Amlodipine Besylate Capsules [Phase 1]

View source ↗

Summary

Phase 1 bioavailability study comparing 10 mg amlodipine besylate orally disintegrating tablets (ODT) with 10 mg amlodipine besylate capsules in healthy volunte…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Amlodipine Besylate ODT (amlodipine besylate)
  • Amlodipine Besylate capsules (amlodipine besylate)
  • Amlodipine besylate (amlodipine besylate)

Snippet

Sponsor: Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | Conditions: Healthy Volunteers | Phase 1 | Status: COMPLETED | Results posted: 2011-08-30